Chau-Ting Yeh Selected Research

Surface Antigens (Surface Antigen)

1/2022	Absence of chronicity in infants born to immunized mothers with occult HBV infection in Taiwan.
9/2021	Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma.
9/2018	Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study.
2/2018	Seroclearance of hepatitis B surface antigen following hepatitis E exacerbation on chronic hepatitis E and B dual infection in a renal transplant recipient: a case report.
1/2017	Platelet counts modulate the quantitative relationship between hepatitis B viral DNA and surface antigen concentrations: a cross-sectional study of hematological, histological and viral factors.
5/2016	Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area.
1/2013	An occult hepatitis B-derived hepatoma cell line carrying persistent nuclear viral DNA and permissive for exogenous hepatitis B virus infection.
2/2007	Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chau-Ting Yeh Research Topics

Disease

98	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 06/2002
87	Neoplasms (Cancer) 02/2024 - 09/2006
35	Chronic Hepatitis B 02/2024 - 01/2002
29	Infections 06/2023 - 06/2002
24	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2008
23	Fibrosis (Cirrhosis) 05/2022 - 06/2002
19	Hepatitis B 02/2024 - 04/2004
18	Liver Neoplasms (Liver Cancer) 03/2024 - 06/2011
17	Hepatitis 01/2019 - 06/2002
9	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023 - 05/2006
9	Hepatitis C 09/2021 - 05/2006
8	Chronic Hepatitis C 04/2021 - 09/2008
8	Inflammation (Inflammations) 05/2018 - 11/2003
7	Carcinogenesis 03/2020 - 08/2009
6	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 04/2016
3	Liver Diseases (Liver Disease) 03/2024 - 01/2012
3	Stomach Neoplasms (Stomach Cancer) 08/2022 - 01/2020
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022 - 01/2010
3	Disease Progression 09/2017 - 03/2007
2	Ascites 01/2023 - 05/2022
2	Non-alcoholic Fatty Liver Disease 05/2022 - 02/2015
2	Hypoxia (Hypoxemia) 01/2022 - 06/2020
2	Virus Diseases (Viral Diseases) 04/2021 - 02/2018
2	Polyps 09/2020 - 09/2019
2	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 02/2017
2	Fatty Liver 06/2018 - 08/2009

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 11/2023 - 02/2005
17	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2003
17	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 10/2003
16	Antiviral Agents (Antivirals)IBA 06/2023 - 10/2003
16	Thyroid HormonesIBA 05/2022 - 03/2008
13	Long Noncoding RNAIBA 01/2022 - 09/2015
10	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2012
10	Lamivudine (Epivir)FDA Link 12/2020 - 11/2003
9	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2007
9	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 09/2008
8	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023 - 06/2002
8	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 10/2018
8	Surface Antigens (Surface Antigen)IBA 01/2022 - 02/2007
8	Hepatitis B e AntigensIBA 05/2015 - 01/2002
7	EnzymesIBA 06/2023 - 05/2012
7	InterferonsIBA 08/2022 - 05/2006
7	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2006
6	Telbivudine FDA Link 01/2023 - 09/2013
6	Alanine Transaminase (SGPT)IBA 01/2021 - 02/2015
5	CytokinesIBA 12/2022 - 04/2016
5	entecavir FDA Link 01/2022 - 09/2013
5	Messenger RNA (mRNA)IBA 12/2021 - 02/2009
5	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 10/2019 - 03/2008
4	Matrix Metalloproteinases (MMPs)IBA 03/2024 - 01/2010
4	BilirubinIBA 12/2022 - 11/2003
4	Nonsense Codon (Nonsense Mutation)IBA 09/2022 - 07/2006
4	Complementary DNA (cDNA)IBA 10/2020 - 08/2003
4	VimentinIBA 01/2020 - 08/2012
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 03/2011
4	N-formylmethionylphenylalanine (FMP)IBA 12/2014 - 03/2011
3	ProteomeIBA 03/2024 - 08/2012
3	Tenofovir (Viread)FDA Link 02/2024 - 10/2021
3	AlbuminsIBA 12/2022 - 01/2013
3	AntigensIBA 01/2022 - 10/2015
3	Fetal Proteins (Fetoprotein)IBA 01/2021 - 07/2014
3	Glucose (Dextrose)FDA LinkGeneric 06/2020 - 05/2016
3	Glutamine (L-Glutamine)FDA Link 01/2020 - 01/2016
3	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2020 - 12/2018
3	AntibodiesIBA 01/2020 - 05/2003
3	Protein Isoforms (Isoforms)IBA 10/2019 - 09/2006
3	NucleotidesIBA 11/2018 - 01/2010
3	MelatoninIBA 09/2018 - 10/2017
3	Triglycerides (Triacylglycerol)IBA 06/2018 - 02/2015
3	CholesterolIBA 05/2018 - 02/2015
3	LipidsIBA 05/2018 - 01/2014
3	AdipokinesIBA 06/2017 - 07/2012
3	Viral DNAIBA 01/2017 - 09/2006
3	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2014 - 03/2011
3	Fluorouracil (Carac)FDA LinkGeneric 12/2014 - 03/2011
2	corylinIBA 11/2023 - 01/2018
2	Fructose-Bisphosphate Aldolase (Aldolase)IBA 10/2023 - 06/2020
2	Globo-HIBA 06/2023 - 01/2022
2	Chaperonin 60IBA 01/2023 - 01/2018
2	SurvivinIBA 01/2023 - 01/2018
2	hepatitis B virus X proteinIBA 01/2023 - 01/2020
2	Cadherins (E-Cadherin)IBA 09/2022 - 04/2016
2	AnticoagulantsIBA 05/2022 - 09/2020
2	Adenosine Triphosphate (ATP)IBA 05/2022 - 05/2014
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2021
2	Calcibiotic Root Canal SealerIBA 12/2021 - 06/2019
2	Interleukin-17 (Interleukin 17)IBA 04/2021 - 01/2021
2	A-factor (Streptomyces)IBA 10/2020 - 09/2019
2	MucinsIBA 02/2020 - 01/2018
2	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2020 - 01/2018
2	CateninsIBA 01/2020 - 03/2012
2	Etoposide (VP 16)FDA LinkGeneric 09/2018 - 01/2018
2	Transaminases (Aminotransferases)IBA 08/2018 - 07/2005

Therapy/Procedure

38	Therapeutics 03/2024 - 04/2004
19	Drug Therapy (Chemotherapy) 02/2024 - 10/2003
5	Liver Transplantation 05/2022 - 01/2012
4	Combination Drug Therapy (Combination Chemotherapy) 12/2014 - 03/2011
3	Ligation 12/2022 - 07/2005
3	Radiotherapy 03/2020 - 09/2017
3	Hepatectomy 01/2017 - 01/2008